Sabra Health Care REIT, Inc. (SBRA)
As of Sep 19, 2026, Sabra Health Care REIT, Inc. (SBRA) scores 4.3/10 on AlphaStocks' five-model composite, #63 of 104 Real Estate stocks. At $20, SBRA trades 12% below its model fair value of $22.
Real Estate / Health Care REITs
S&P MidCap 400$19.76
Below average on several measures. Research carefully.
Weak
Score based on 5 of 5 models — high confidence
Data as of Sep 19, 2026
Is Sabra Health Care REIT, Inc. a Good Investment in 2026?
Sabra Health Care REIT, Inc. (SBRA) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates Sabra Health Care REIT, Inc. as Attractive. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 2.0% · ROC 3%. Sabra Health Care REIT, Inc. currently trades 12% below its estimated fair value of $22. Sabra Health Care REIT, Inc. ranks #63 out of 104 stocks in the Real Estate sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading below estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/8
Buffett
Attractive
Business quality & competitive moat
Graham
Attractive
Significantly above fair value
Lynch
Neutral
High PEG — growth premium · Slow Grower
Greenblatt
Caution
Earnings yield 2.0% · ROC 3%
Frequently Asked Questions
Is Sabra Health Care REIT, Inc. (SBRA) a good investment?
What is Sabra Health Care REIT, Inc.'s Piotroski F-Score?
Is SBRA overvalued or undervalued?
How does SBRA compare to other Real Estate stocks?
What do investment models say about SBRA?
Similar Stocks
Compare SBRA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer